Reactions Weekly

, Volume 1222, Issue 1, pp 3–3 | Cite as

Inhaled anticholinergics: increased risk of major adverse CV events?

News item


Chronic Obstructive Pulmonary Disease Tiotropium Ipratropium Ipratropium Bromide Nonfatal Stroke 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Singh S, Loke YK, Furberg CD.Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA: the Journal of the American Medical Association 300: 1439-1450, No. 12, 24 Sep 2008Google Scholar
  2. 2.
    Boehringer Ingelheim.Established Safety Profile of SPIRIVA(R) Confirmed by 30 Rigorously Controlled Clinical Trials. Media Release: 23 Sep 2008. Available from: URL:

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations